Delayed antibody treatment may improve efficacy of mRNA vaccines

Investigators led by Pablo Penaloza-MacMaster, Ph.D., associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination enhances immune responses and vaccine efficacy in mice, according to a recent study published in The Journal of Clinical Investigation.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup